PM
TNDM icon

Parametrica Management’s Tandem Diabetes Care TNDM Stock Holding History

Parametrica Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-4,083
Closed -$263K – 264
2020
Q1 		$263K Buy
+4,083
New +$286K 0.27% 117

Other funds holding TNDM

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Parametrica Management's TNDM Position: Q2 2020 in Review

Parametrica Management sold out of Tandem Diabetes Care (TNDM) in Q2 2020, closing a stake of 4,083 shares — an estimated $263K sold.

Parametrica Management first reported a position in TNDM in Q1 2020 and held it in 1 quarter. The position peaked at $263K in Q1 2020. 303 funds tracked by Wall St. Rank hold TNDM as of Q2 2020.

  • Parametrica Management reported no remaining Tandem Diabetes Care position as of Q2 2020 after selling out during the quarter.
  • Parametrica Management sold 4,083 Tandem Diabetes Care shares in Q2 2020, an estimated $263K.
  • Parametrica Management first reported a position in Tandem Diabetes Care in Q1 2020 and held it in 1 quarter.
  • Parametrica Management's Tandem Diabetes Care position peaked at $263K in Q1 2020.
  • 303 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2020.

Based on Parametrica Management's 13F filing for Q2 2020, filed 17 Aug 2020.